Cargando…
Calreticulin enhances gastric cancer metastasis by dimethylating H3K9 in the E-cadherin promoter region mediating by G9a
The latest study shows that gastric cancer (GC) ranked the fifth most common cancer (5.6%) with over 1 million estimated new cases annually and the fourth most common cause of cancer death (7.7%) globally in 2020. Metastasis is the leading cause of GC treatment failure. Therefore, clarifying the reg...
Autores principales: | Wang, Lina, Chen, Jun, Zuo, Qianfei, Wu, Chunmei, Yu, Ting, Zheng, Pengfei, Huang, Hui, Deng, Jun, Fang, Lichao, Liu, Huamin, Li, Chenghong, Yu, Peiwu, Zou, Quanming, Zheng, Junsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156786/ https://www.ncbi.nlm.nih.gov/pubmed/35641480 http://dx.doi.org/10.1038/s41389-022-00405-7 |
Ejemplares similares
-
Calreticulin Exon 9 Mutations in Myeloproliferative Neoplasms
por: Ha, Jung-Sook, et al.
Publicado: (2015) -
Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis
por: Chi, J, et al.
Publicado: (2014) -
9,9-Dimethyl-9-silafluorene
por: Mewes, Jan, et al.
Publicado: (2009) -
Snail2 induced E-cadherin suppression and metastasis in lung carcinoma facilitated by G9a and HDACs
por: Hu, Yue, et al.
Publicado: (2019) -
9,9-Dimethyl-9,10-dihydroanthracene
por: Siddaraju, B. P., et al.
Publicado: (2011)